![](/img/cover-not-exists.png)
DOP54 Efficacy and safety of ustekinumab through Week 16 in patients with moderate-to-severe ulcerative colitis randomised to ustekinumab: results from the UNIFI induction trial
Danese, S, Sands, B E, O'Brien, C D, Zhang, H, Johanns, J, Sloan, S, Izanec, J, Szapary, P, Marano, C, Leong, R W, Rowbotham, D, Targan, S R, Van Assche, GVolume:
13
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.088
Date:
January, 2019
File:
PDF, 828 KB
2019